The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy of abiraterone and enzalutamide in patients who had disease progression within twelve months of completing docetaxel for metastatic castration sensitive prostate cancer.
 
Gang Chen
No Relationships to Disclose
 
David James VanderWeele
No Relationships to Disclose
 
Fatima Karzai
No Relationships to Disclose
 
Marijo Bilusic
Research Funding - Bavarian Nordic (Inst)
 
Munjid Al Harthy
No Relationships to Disclose
 
Philip M. Arlen
Employment - Precision Biologics
Leadership - Precision Biologics
Stock and Other Ownership Interests - Precision Biologics
Patents, Royalties, Other Intellectual Property - have patents held by Precision Biologics
 
Inger L. Rosner
No Relationships to Disclose
 
Guinevere Chun
No Relationships to Disclose
 
Helen Owens
No Relationships to Disclose
 
Anna Couvillon
No Relationships to Disclose
 
Amy Hankin
No Relationships to Disclose
 
Monique Williams
No Relationships to Disclose
 
Lisa M. Cordes
No Relationships to Disclose
 
William Douglas Figg
Research Funding - Astellas Pharma (Inst); Biocompatibles (Inst); Celgene (Inst); Nerviano Medical Sciences (Inst); NovaRX (Inst); Pfizer (Inst); TRACON Pharma (Inst)
 
James L. Gulley
Research Funding - Astellas Medivation (Inst); Bavarian Nordic (Inst); Bristol-Myers Squibb (Inst); EMD Serono (Inst); Merck (Inst); NantBioScience (Inst); Pfizer (Inst)
 
William L. Dahut
No Relationships to Disclose
 
Ravi Amrit Madan
Speakers' Bureau - Boehringer Ingelheim (I); Janssen (I); Pfizer (I)